InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Tuesday, 06/25/2013 7:03:09 AM

Tuesday, June 25, 2013 7:03:09 AM

Post# of 426487
New FDA combo guidance doesn't look good for AZN if they planned to seek an Epanova/Crestor combo as an initial application.

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM236669.pdf

AZN's combo runs into more than one wall in this guidance. It was posted 6-19-2013, same date the Ad Com was announced.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News